These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 8619564)

  • 1. Growth inhibition of Ureaplasma urealyticum by the proton pump inhibitor lansoprazole: direct attribution to inhibition by lansoprazole of urease activity and urea-induced ATP synthesis in U. urealyticum.
    Nagata K; Takagi E; Satoh H; Okamura H; Tamura T
    Antimicrob Agents Chemother; 1995 Oct; 39(10):2187-92. PubMed ID: 8619564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory action of lansoprazole and its analogs against Helicobacter pylori: inhibition of growth is not related to inhibition of urease.
    Nagata K; Takagi E; Tsuda M; Nakazawa T; Satoh H; Nakao M; Okamura H; Tamura T
    Antimicrob Agents Chemother; 1995 Feb; 39(2):567-70. PubMed ID: 7726537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent inhibitory action of the gastric proton pump inhibitor lansoprazole against urease activity of Helicobacter pylori: unique action selective for H. pylori cells.
    Nagata K; Satoh H; Iwahi T; Shimoyama T; Tamura T
    Antimicrob Agents Chemother; 1993 Apr; 37(4):769-74. PubMed ID: 8494373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Helicobacter pylori urease inhibition by rabeprazole, a proton pump inhibitor.
    Tsuchiya M; Imamura L; Park JB; Kobashi K
    Biol Pharm Bull; 1995 Aug; 18(8):1053-6. PubMed ID: 8535394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth inhibitory and bactericidal activities of lansoprazole compared with those of omeprazole and pantoprazole against Helicobacter pylori.
    Nakao M; Malfertheiner P
    Helicobacter; 1998 Mar; 3(1):21-7. PubMed ID: 9546114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxygen concentration influences proton pump inhibitor activity against Helicobacter pylori in vitro.
    Midolo PD; Turnidge JD; Lambert JR; Bell JM
    Antimicrob Agents Chemother; 1996 Jun; 40(6):1531-3. PubMed ID: 8726032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities.
    Li XQ; Andersson TB; Ahlström M; Weidolf L
    Drug Metab Dispos; 2004 Aug; 32(8):821-7. PubMed ID: 15258107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibacterial properties of lansoprazole alone and in combination with antimicrobial agents against Helicobacter pylori.
    Nakao M; Tada M; Tsuchimori K; Uekata M
    Eur J Clin Microbiol Infect Dis; 1995 May; 14(5):391-9. PubMed ID: 7556227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Helicobacter pylori infection, chronic gastritis, and proton pump inhibitors.
    Dattilo M; Figura N
    J Clin Gastroenterol; 1998; 27 Suppl 1():S163-9. PubMed ID: 9872516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Negative Effect of Proton-pump Inhibitors (PPIs) on Helicobacter pylori Growth, Morphology, and Urease Test and Recovery after PPI Removal--An In vitro Study.
    Saniee P; Shahreza S; Siavoshi F
    Helicobacter; 2016 Apr; 21(2):143-52. PubMed ID: 26222264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of omeprazole, lansoprazole, pantoprazole, and rabeprazole in the treatment of acid-related diseases.
    Welage LS; Berardi RR
    J Am Pharm Assoc (Wash); 2000; 40(1):52-62; quiz 121-3. PubMed ID: 10665250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of proton pump inhibitors on the detection of Helicobacter pylori in gastric biopsies.
    Dickey W; Kenny BD; McConnell JB
    Aliment Pharmacol Ther; 1996 Jun; 10(3):289-93. PubMed ID: 8791953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of omeprazole, lansoprazole and pantoprazole with P-glycoprotein.
    Pauli-Magnus C; Rekersbrink S; Klotz U; Fromm MF
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Dec; 364(6):551-7. PubMed ID: 11770010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori.
    Iwahi T; Satoh H; Nakao M; Iwasaki T; Yamazaki T; Kubo K; Tamura T; Imada A
    Antimicrob Agents Chemother; 1991 Mar; 35(3):490-6. PubMed ID: 2039199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The chemotherapeutic effects of H+/K+ inhibitors on Helicobacter pylori infection.
    Logan RP
    Pharmacol Ther; 1996; 69(1):79-83. PubMed ID: 8857304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different effects of short-term omeprazole, lansoprazole or pantoprazole on the accuracy of the (13)C-urea breath test.
    Parente F; Sainaghi M; Sangaletti O; Imbesi V; Maconi G; Anderloni A; Bianchi Porro G
    Aliment Pharmacol Ther; 2002 Mar; 16(3):553-7. PubMed ID: 11876710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of hyphal growth of Candida albicans by activated lansoprazole, a novel benzimidazole proton pump inhibitor.
    Biswas SK; Yokoyama K; Kamei K; Nishimura K; Miyaji M
    Med Mycol; 2001 Jun; 39(3):283-5. PubMed ID: 11446532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydrolysis of urea by Ureaplasma urealyticum generates a transmembrane potential with resultant ATP synthesis.
    Smith DG; Russell WC; Ingledew WJ; Thirkell D
    J Bacteriol; 1993 Jun; 175(11):3253-8. PubMed ID: 8501029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial actions of benzimidazoles against oral streptococci.
    Nguyen PT; Baldeck JD; Olsson J; Marquis RE
    Oral Microbiol Immunol; 2005 Apr; 20(2):93-100. PubMed ID: 15720569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of quadruple therapy using lansoprazole, instead of omeprazole, in curing Helicobacter pylori infection.
    de Boer WA; van Etten RJ; Lai JY; Schneeberger PM; van de Wouw BA; Driessen WM
    Helicobacter; 1996 Sep; 1(3):145-50. PubMed ID: 9398895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.